Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiViDInt: Pleconaril and Ribavirin in New-Onset Type 1 Diabetes
NCT04838145Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Aug 2018
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pleconaril, ribavirin in type 1 diabetes mellitus (T1D), sponsored by Oslo University Hospital. Started Aug 2018; status: completed.
02
Drugs
pleconarilribavirin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04838145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04838145.